Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Aims: Ossifying fibromyxoid tumour is a rare mesenchymal neoplasm predominantly affecting adults characterised by a multinodular growth pattern and the presence of a fibrous pseudocapsule with areas of ossification. Prompted by the recognition of a non-ossifying ossifying fibromyxoid tumour with lipomatous differentiation which caused diagnostic difficulty, we sought to further explore cases of ossifying fibromyxoid tumour with non-osseous heterologous elements.
Methods And Results: A search of our institutional and consultation archives revealed three additional cases that demonstrated lipomatous components and two cases with cartilaginous differentiation. RNA-sequencing revealed fusions involving PHF1 (n = 4) or EPC1 (n = 1) in all (five of five) cases tested, including EPC1::PHC1 and JAZF1::PHF1 fusions, which have not been reported before in ossifying fibromyxoid tumour.
Conclusion: These six cases expand the histomorphological spectrum of ossifying fibromyxoid tumour, introducing lipomatous differentiation as a hitherto undocumented feature. Awareness of these rare variants will ensure appropriate diagnosis and clinical management.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11964580 | PMC |
| http://dx.doi.org/10.1111/his.15396 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ossifying fibromyxoid tumor: a rare case involving the paraspinal musculature and spinous processes.
Skeletal Radiol
August 2025
Department of Radiology, Beth Israel Deaconess Medical Center (BIDMC), Boston, MA, USA.
Ossifying fibromyxoid tumors (OFMT) are rare tumors with an intermediate risk of malignancy that are usually found in the extremities. To date, only three cases of OFMTs involving the paraspinal musculature have been reported in the literature. Two of these previously reported cases demonstrated poorly circumscribed tumors with involvement of adjacent osseous and soft tissue structures.
View Article and Find Full Text PDFZC3H7A/B::BCOR fusion fibromyxoid sarcoma of soft tissue: an emerging aggressive sarcoma overlapping with malignant ossifying fibromyxoid tumors.
Virchows Arch
July 2025
Department of Pathology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
BCOR-rearranged sarcomas constitute ultra-rare tumors. Among these, ZC3H7A/B::BCOR sarcomas are less common and are primarily reported as a subset of high-grade endometrial stromal sarcomas, as well as in the spectrum of malignant ossifying fibromyxoid tumors (OFMTs). Herein, we present the clinicopathological, immunohistochemical, and molecular profiles of seven soft tissue tumors exhibiting ZC3H7A/B::BCOR fusions.
View Article and Find Full Text PDFOssifying Spindled and Epithelioid Tumor: A Novel Soft Tissue Tumor.
Mod Pathol
July 2025
Department of Pathology, University of Miami and Miller School of Medicine, Miami, Florida.
This investigation describes the clinicoradiologic, pathologic, and molecular features of a unique soft tissue tumor characterized by a peripheral shell of bone and composed of bland myoid spindle and epithelioid cells that are keratin-positive. Our study cohort consists of 6 men and 6 women, with a mean age of 32 years. The tumors arose in the extremities (n = 9) and proximal limb girdle (n = 3) and were equally distributed between deep and superficial soft tissues.
View Article and Find Full Text PDFUterine Mesenchymal Neoplasm With BRD8::PHF1 Fusion: Low-grade Endometrial Stromal Sarcoma or Uterine Ossifying Fibromyxoid Tumor?
Int J Gynecol Pathol
July 2025
Department of Pathology, Belfast Health and Social Care Trust, Belfast.
We report an unusual uterine polypoid mesenchymal tumor in a 52-year-old resembling the soft tissue neoplasm ossifying fibromyxoid tumor (OFMT). The neoplasm was morphologically low-grade with hypocellular areas containing bland spindle cells in a fibromyxoid stroma, cellular areas resembling typical low-grade endometrial stromal sarcoma (LGESS), and abundant mature bone. The cellular areas were ER and CD10 positive and cyclin D1 negative, and the hypocellular areas were ER and CD10 negative, with approximately 50% of the nuclei being cyclin D1 positive.
View Article and Find Full Text PDFLetter Re: Ossifying fibromyxoid tumours: A case series subtitle: Successful control of a PHF1::TFE3-rearranged metastatic malignant ossifying fibromyxoid tumor using cabozantinib.
Eur J Cancer
July 2025
Massey Comprehensive Cancer Center, Richmond, VA 23298, United States. Electronic address: